Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.36 |
| ▸ | MLKL | Q8NB16 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KAT6A | Q92794 | 2/20 | 0.34 |
| ▸ | APLNR | P35414 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14582535 | 0.91 | APLNR (0.36) | RXFP1MLKLTHRBKAT6AAPLNR | |
| SCHEMBL2615681 | 0.89 | NPC1 (0.37) | MLKLKAT6AALDH1A1GAANPC1 | |
| SCHEMBL13936700 | 0.89 | MLKL (0.33) | MLKLNPC1RAB9A | |
| SCHEMBL3826176 | 0.88 | MLKL (0.35) | MLKL | |
| SCHEMBL2615674 | 0.88 | CCR9 (0.39) | MLKLSMN1; SMN2HPGD | |
| SCHEMBL3834184 | 0.88 | MLKL (0.33) | MLKLALDH1A1NPC1CA1CA2 | |
| SCHEMBL9953390 | 0.83 | NPC1 (0.34) | MLKLKAT6AALDH1A1GAANPC1 | |
| SCHEMBL10067866 | 0.82 | KMT2A (0.40) | ALDH1A1NPC1POLBSMN1; SMN2KDM4E | |
| SCHEMBL13168812 | 0.82 | CCR9 (0.36) | MLKL | |
| SCHEMBL3803834 | 0.82 | CASK (0.30) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096551-B2 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9096551-B2 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-9096551-B2 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| EP-2655346-B1 | PROCESS FOR THE PREPARATION OF 2-(TRIAZINYLCARBONYL)SULFONANILIDES | BAYER IP GMBH (DE) | 2015-01-21 | — | — | EP | disclosed |
| EP-2655346-B1 | PROCESS FOR THE PREPARATION OF 2-(TRIAZINYLCARBONYL)SULFONANILIDES | BAYER IP GMBH (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-23 | — | — | US | disclosed |
| WO-2012084857-A2 | METHOD FOR PRODUCING 2-(TRIAZINYLCARBONYL) SULFONANILIDES | BAYER CROPSCIENCE AG (DE) | 2012-06-28 | — | — | WO | disclosed |
| US-20100323896-A1 | USE OF SULFONANILIDES AS HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | US | disclosed |
| US-20090305894-A1 | use of sulfonanilides as herbicide | BAYER CROPSCIENCE AG (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | AOX1, SULT1E1, CBR1 | RXFP1 3369/4885MLKL 3512/4885THRB 3031/4885 |
| US-20100323896-A1 | USE OF SULFONANILIDES AS HERBICIDE | CBR3, HCAR3, HCRTR1 | RXFP1 671/4885MLKL 4541/4885THRB 1284/4885 |
| US-20090305894-A1 | use of sulfonanilides as herbicide | CBR3, HCAR3, CBR1 | RXFP1 675/4885MLKL 4559/4885THRB 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.